Adirondack Research & Management’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.72M Buy
91,700
+1,700
+2% +$35.8K 2.09% 7
2021
Q2
$1.86M Sell
90,000
-36,398
-29% -$704K 2.17% 5
2021
Q1
$2.11M Sell
126,398
-12,700
-9% -$214K 2.49% 3
2020
Q4
$2.05M Sell
139,098
-61,097
-31% -$776K 2.81% 5
2020
Q3
$2.05M Sell
200,195
-56,609
-22% -$642K 2.86% 8
2020
Q2
$2.81M Sell
256,804
-49,893
-16% -$515K 3.68% 3
2020
Q1
$2.35M Hold
306,697
3.28% 4
2019
Q4
$3.03M Buy
306,697
+10,642
+4% +$101K 2.63% 12
2019
Q3
$3.36M Hold
296,055
2.93% 8
2019
Q2
$4.51M Sell
296,055
-33,897
-10% -$541K 3.24% 5
2019
Q1
$4.52M Sell
329,952
-10,398
-3% -$144K 2.82% 5
2018
Q4
$3.65M Buy
340,350
+10,700
+3% +$146K 2.29% 14
2018
Q3
$5.82M Hold
329,650
2.18% 13
2018
Q2
$4.89M Buy
329,650
+19,836
+6% +$296K 1.91% 17
2018
Q1
$4.82M Buy
+309,814
New +$5.17M 1.93% 15

Other funds holding ADTN

Adirondack Research & Management's ADTN Position: Q3 2021 in Review

Adirondack Research & Management increased its Adtran (ADTN) stake by 1.9% in Q3 2021, buying an estimated $35.8K and bringing the position to 91,700 shares worth $1.72M. The position accounts for 2.09% of the portfolio, ranked #7.

Adirondack Research & Management first reported a position in ADTN in Q1 2018 and has held it in 15 quarters since. The position peaked at $5.82M in Q3 2018. 175 funds tracked by Wall St. Rank hold ADTN as of Q3 2021.

  • Adirondack Research & Management held 91,700 shares of Adtran worth $1.72M as of Q3 2021.
  • Adirondack Research & Management bought 1,700 Adtran shares in Q3 2021, an estimated $35.8K.
  • Adtran made up 2.09% of Adirondack Research & Management's portfolio in Q3 2021, its #7 holding.
  • Adirondack Research & Management first reported a position in Adtran in Q1 2018 and has held it in 15 quarters since.
  • Adirondack Research & Management's Adtran position peaked at $5.82M in Q3 2018.
  • 175 funds tracked by Wall St. Rank held Adtran as of Q3 2021.

Based on Adirondack Research & Management's 13F filing for Q3 2021, filed 29 Oct 2021.